Kensey Nash (KNSY) Tops Q4 View; Guides FY08/FY09
More News related to KNSY
- Jefferies & Co Initiates Coverage on Kensey Nash (KNSY)
- Kensey Nash (KNSY) Tops Q3 EPS View by 6c; Raises FY09 EPS Guidance; CFO Resigns
- Kensey Nash Corporation Announces Resignation of Chief Financial Officer
- Kensey Nash Reports First Quarter Fiscal Year 2009 Results
- Kensey Nash to Present at the Sidoti & Company New York Emerging Growth Institutional Investor Conference II
More News related to Earnings
- Post Properties (PPS) Announces Reduction In Quarterly Dividend To 20c, CIO Departure and New Stock Buyback Of Up To $200M
- Roberts Realty Investors (RPI) Increases Stock Repurchase Program
- United American Healthcare (UAHC) Approves $1 Million Stock Buyback
- Quidel Corporation (QDEL) Extends Current Stock Buyback Plan
- Quidel (QDEL) Adds $25M to Buyback Program
Kensey Nash Corporation (Nasdaq: KNSY) reports Q4 adj-EPS of $0.35, 3 cents better than the analyst estimate of $0.32. Revenues for the quarter were $22 million, versus the consensus of $21.05 million.
Sees FY08 sales in the range of $58-$60 million, versus the consensus of $78.87 million and FY09 revs in the range of $86.7-$89 million, versus the Street estimate of $86.34 million. Sees FY09 EPS of $1.60-$1.67, versus the consensus of $1.61.
Kensey Nash Corporation, a medical device company, develops products and technologies in the fields of biomaterials and endovascular devices used in various medical procedures.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.56Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
